Jinhua Liang
he First Affiliated Hospital with Nanjing Medical University, Nanjing, China
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
yue lu, MD.
Department of Hematological Oncology, Sun Yat-sen University Cancer Center
Shared therapeutic areas:
Stefano Luminari, MD
Ematologia, AUSL IRCCS Reggio Emilia
Shared therapeutic areas:
Wyndham H Wilson, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
ZhongJun Xia, MD/PHD
Department of Hematological Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China,
Shared therapeutic areas:
Weili Zhao, MD
Shanghai Rui Jin Hospital,Shanghai Jiao Tong University - School of Medicine
Shared therapeutic areas:
Helen Heslop, MD
Baylor College of Medicine
Shared therapeutic areas:
James N Kochenderfer, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Pablo Ortiz, MD, PhD
Hospital 12 de Octubre
Shared therapeutic areas:
Ting Liu, MD
West China Hospital
Shared therapeutic areas:
Kurt Gunter, MD
Cell Medica
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.
All 1 trials loaded